GLP-1 Receptor Agonists and Weight Loss – Is There an Alternative?
Glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists) are a newer class of injectable medications that were designed to control blood sugars for diabetics. These medications tell the body it must produce more insulin, releasing sugar as needed.
After food consumption, pancreatic cells are signaled to release insulin into your bloodstream. If you have more sugar in your body than it requires, the insulin helps store the sugar in your liver, and subsequently releases it when blood sugar levels are low. This function is compromised in type-2 diabetics which is why GLP-1 receptor agonists are suggested. GLP-1 receptor agonists also mitigate weight gain, something that type-2 diabetics struggle with. Weight gain is a common side effect for those who take insulin, which is a frustrating conundrum to be in given that healthy weight maintenance is a critical part of a diabetes management plan.
GLP-1 receptor agonist applications in type-2 diabetic weight loss have implications for many other Canadians. But is a GLP-1 agonist injection the way to go? For a type-2 diabetic it can be, but it’s not exactly an appealing prospect for others concerned about obesity. Thankfully, there is an alternative available to the general Canadian public made available by Metagenics Ultra Flora Control. Let’s review.
Why Metagenics UltraFlora Control May Be an Alternative to GLP-1 Receptor Agonists for Losing Unhealthy Weight
Bifidobacterium Absorption an Answer to GLP-1 Agonists’ Short Half-Life
While GLP-1 agonists improve pancreatic function and are known to help treatment type 2 diabetes while mitigating weight gain its short half-life limits therapeutic applications. To work around this problem, experts looked to Bifidobacterium (a probiotic naturally occurring in the intestinal flora) to express a secreted and biologically active form of the GLP-1. Resulting data found that Bifidobacterium delivered a fully functional GLP-1 and displayed significantly enhanced absorption in the colon.
Metagenics UltraFlora Control contains Bifidobacterium lactis, also referred to as B. lactis. As mentioned, the bacterium secretes a GLP-1-like substance that works in the same manner but with improved absorption.
An Alternative to Potential GLP-1 Agonist Side Effects
GLP-1 Agonist injections may come with mild to more severe side effects, including but not exclusive to nausea, vomiting, diarrhea, headache, weakness, and dizziness – all of which are the most common. Injection site reactions are also of concern. There is also some debate over the safety profile of GLP-1 Agonist injectable due to proliferative effects in the pancreas. But when leveraging the natural Bifidobacterium benefits through Metaggenics UltraFlora Control (a natural health supplement) the risk of side effects is much lower.
An Alternative to Injections
One of the biggest public stresses regarding the use of a GLP-1 Agonist is the fact that it is an injectable. If you’re like most people who sit on pins and needles while awaiting to get the needle, you’ll be pleased to know that you have a much preferable alternative. Metaggenics UltraFlora Control comes in easy to swallow capsules. In addition, GLP-1 Agonist injections are very expensive, whereas Metagenics UltraFlora Control is available to Canadians for just over $50 CAD.
Other Weight Management Benefits of Bifidobacterium lactis B-420
Research has shown that Bifidobacterium lactis B-420 offers additional weight management benefits and properties, including the following:
- Reduced appetite
- Increase in Short Chain Fatty Acids
- Controlled body fat
- Controlled body weight
- Decreased plasma Lipopolysaccharide levels
- Decreased liver inflammation
- Decreased levels of circulating zonulin
InnerGood has already covered the full spectrum of weight management benefits of Metagenics UltraFlora Control for those who want to dig deeper before making their purchase decision. View the breakdown here or simply contact us with any further questions you may have.
Disclaimer: InnerGood does not purport UltraFlora Control to be an alternative to GLP-1 Receptor Agonist treatment for type-2 diabetes. Consult with your physician before taking UltraFlora Control if you suffer from type-2 diabetes or any other related health condition.